NLRP3 inflammasome inhibitors (China Pharmaceutical University)

N/A

Report date: 2025/01/26 17:24:13

NME

Base Information

Drug NameNLRP3 inflammasome inhibitors (China Pharmaceutical University)

Drug Alias NameNACHT LRR PYD domain protein 3 inhibitors (China Pharmaceutical University)NOD-like receptor family pyrin domain containing 3 inhibitors (China Pharmaceutical University)NLR family pyrin domain containing 3 inhibitors (China Pharmaceutical University)DB-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors

TargetsNACHT, LRR and PYD domains-containing protein 3

Therapy Area/IndicationsColitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChina Pharmaceutical University

China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University

Inactive CompaniesN/A

Active IndicationsColitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A